发明名称 Compositions employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
摘要 Provided are alternative reading frame (ARF) polypeptides as well as antigen presenting cell (APC) and dendritic cell (DC) based compositions that comprise ARF polypeptides. ARF polypeptides and ARF polypeptide-based compositions are useful in the treatment of cancer and infectious disease.
申请公布号 US9051385(B2) 申请公布日期 2015.06.09
申请号 US200912573685 申请日期 2009.10.05
申请人 DENDREON CORPORATION 发明人 Graddis Thomas;Laus Reiner;Diegel Michael;Vidovic Damir
分类号 A61K39/00;C07K14/47 主分类号 A61K39/00
代理机构 King & Spalding LLP 代理人 King & Spalding LLP
主权项 1. A polypeptide conjugate comprising an N-terminal moiety and a C-terminal moiety, wherein said N-terminal moiety comprises one or more ARF polypeptides and said C-terminal moiety comprises a polypeptide moiety that facilitates binding of said ARF polypeptide to an antigen presenting cell (APC), and wherein each said ARF polypeptide comprises at least 9 amino acids of an ARF polypeptide encoded by a human tyrosine kinase receptor (hHER-2) polynucleotide represented by SEQ ID NO: 2 and has a sequence selected from SEQ ID NOs: 71-95 and fragments thereof comprising at least 9 amino acids.
地址 Seattle WA US